When.com Web Search

  1. Ads

    related to: secretion management in myasthenia gravis disease
    • FAQ

      Get Answers To Your Questions.

      Learn More On The Official Site!

    • Resources

      Review Helpful Information About

      Generalized Myasthenia Gravis.

Search results

  1. Results From The WOW.Com Content Network
  2. Myasthenia gravis is one of the rarest and most concerning ...

    www.aol.com/myasthenia-gravis-one-rarest-most...

    Myasthenia gravis, or MG, is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue. ... The disease disrupts communication between nerves and muscles, she explains ...

  3. Myasthenia gravis - Wikipedia

    en.wikipedia.org/wiki/Myasthenia_gravis

    Myasthenia gravis (MG) is a long-term neuromuscular junction disease that leads to varying degrees of skeletal muscle weakness. [1] The most commonly affected muscles are those of the eyes , face , and swallowing.

  4. Pyridostigmine - Wikipedia

    en.wikipedia.org/wiki/Pyridostigmine

    Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.

  5. Cholinergic crisis - Wikipedia

    en.wikipedia.org/wiki/Cholinergic_crisis

    Flaccid paralysis resulting from cholinergic crisis can be distinguished from myasthenia gravis by the use of the drug edrophonium (Tensilon), as it only worsens the paralysis caused by cholinergic crisis but strengthens the muscle response in the case of myasthenia gravis. Edrophonium is a cholinesterase inhibitor, hence it increases the ...

  6. Neuromuscular junction disease - Wikipedia

    en.wikipedia.org/wiki/Neuromuscular_junction_disease

    Acquired myasthenia gravis is the most common neuromuscular junction disease.(reference 7) Important observations were made by Patrick and Lindstrom in 1973 when they found that antibodies attacking the acetylcholine receptors were present in around 85% of cases of myasthenia gravis.(reference renamed form 13)(reference 36) The remaining ...

  7. Ocular myasthenia - Wikipedia

    en.wikipedia.org/wiki/Ocular_myasthenia

    Ocular myasthenia gravis (MG) is a disease of the neuromuscular junction resulting in hallmark variability in muscle weakness and fatigability. MG is an autoimmune disease where anomalous antibodies are produced against the naturally occurring acetylcholine receptors in voluntary muscles. MG may be limited to the muscles of the eye (ocular MG ...

  1. Ads

    related to: secretion management in myasthenia gravis disease